cAMP signaling pathway and multiple myeloma

doi:10.3760/cma.j.issn.1673-422X.2014.05.015

Abstract

Abstract: The clonal proliferations of multiple myeloma cells consist of several signaling pathways. It has been shown that cyclic adenosine monophosphate (cAMP) signaling pathway, an important intracellular messenger delivery system, is related to abnormal proliferation and apoptosis of malignant lymphoid cells including myeloma cells. Manipulating the cAMP signaling pathway could induce cell cycle arrest and apoptosis of various malignant lymphoid cells including myeloma cells, which involve mitochondrialdependent apoptosis and cAMPmodulated changes of intracellular mediators. Indepth researches and analysis of cAMPinduced apoptosis in myeloma cells would provide potential targets and possible therapeutic means in the treatment of multiple myeloma.

Key words: Multiple myeloma, Cyclic AMP, Apoptosis

Wang Yingying, Zhu Qi. cAMP signaling pathway and multiple myeloma[J]. Journal of International Oncology, 2014, 41(5): 368-370.

References

［1］ Landgren O, Korde N. Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities［J］. Oncology (Williston Park), 2011, 25(7): 589-590. ［2］ Insel PA, Zhang L, Murray F, et al. Cyclic AMP is both a proapoptotic and antiapoptotic second messenger［J］. Acta Physiol, 2012, 204(2):277-287. ［3］ Zhang L, Zambon AC, Vranizan K, et al. Gene expression signatures of cAMP/protein kinase A (PKA)promoted, mitochondrialdependent apoptosis. Comparative analysis of wildtype and cAMPdeathless S49 lymphoma cells［J］. J Biol Chem, 2008, 283(7):4304-4313. ［4］ Mantovani G, Bondioni S, Lania AG, et al. High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells［J］. Oncogene, 2008， 27(13):1834-1843. ［5］ Bouizar Z, Ragazzon B, Viou L, et al. 8ClcAMP modifies the balance between PKAR1 and PKAR2 and modulates the cell cycle, growth and apoptosis in human adreoncortical H295R cells［J］. J Mol Endocrinol, 2010, 44(6):331-347. ［6］ FollinArbelet V, Hofgaard PO, Hauglin H, et al. Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model［J］. BMC Cancer, 2011, 11: 301. ［7］ Rickles RJ, Pierce LT, Giordano TP 3rd, et al. Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in Bcell malignancies［J］. Blood, 2010, 116(4):593-602. ［8］郭玉琪, Zhenfeng Duan, 张展. IL6/STAT3信号传导通路及其在肿瘤靶向治疗中的作用［J］. 国际肿瘤学杂志, 2011, 38(6):427-429. ［9］ FollinArbelet V, Torgersen ML, Naderi EH, et al. Death of multiple myeloma cells induced by cAMPsignaling involves downregulation of Mcl1 via the JAK/STAT pathway［J］. Cancer Lett, 2013, 335(2):323-331. ［10］ Song J, Li Y, Shen B. Activation of PKA pathway inhibits reactivity of human myeloma cell lineU266 to IL6［J］. Zhonghua Zhong Liu Za Zhi, 2001, 23(4):278-280. ［11］ Baumann P, MandlWeber S, Emmerich B, et al. Inhibition of adenosine monophosphateactivated protein kinase induces apoptosis in multiple myeloma cells［J］. Anticancer Drugs, 2007, 18(4):405-410. ［12］ Leone V, di Palma A, Ricchi P, et al. PGE2 inhibits apoptosis in human adenocarcinoma Caco2 cell line through RasPI3K association and cAMPdependent kinase A activation［J］. Am J Physiol Gastrointest Liver Physiol, 2007, 293(4):G673-681. ［13］ McMurray JJ. Clinical practice. Systolic heart failure［J］. N Engl J Med, 2010, 362(3):228-238. ［14］ Misra UK, Pizzo SV. Coordinate regulation of forskolininduced cellular proliferation in macrophages by protein kinase A/cAMPresponse elementbinding protein (CREB) and Epac1Rap1 signaling: effects of silencing CREB gene expression on Akt activation［J］. J Biol Chem, 2005, 280(46):38276-38289.

[1]	Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan. Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity， proliferation， and apoptosis of multiple myeloma cells [J]. Journal of International Oncology, 2024, 51(3): 129-136.
[2]	Zhang Keping, Zhao Yongsheng, Yang Juan, Fu Maoyong. Chlorogenic acid induces mitochondrial dysfunction in lung cancer A549 cells by inhibiting the PI3K-Akt pathway [J]. Journal of International Oncology, 2024, 51(1): 21-28.
[3]	Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong. Effects of Anhydroicaritin on the proliferation， migration and apoptosis of hepatocellular carcinoma cells [J]. Journal of International Oncology, 2023, 50(9): 513-519.
[4]	Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng. Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway [J]. Journal of International Oncology, 2023, 50(8): 449-456.
[5]	Wu Jiali, Zhang Jiahui, Zhang Ping, Xiao Xinyue, Li Rui, Zhang Hongyu. Mechanism of Bcl-2 BH4 selective inhibitor BDA-366 on NK/T cell lymphoma cells [J]. Journal of International Oncology, 2023, 50(7): 413-418.
[6]	Yang Ya, Wang Huili, Liu Yan, Guo Jinfeng, Wang Chunxia, Lyu Min, Shan Changping. Effects of GCSH gene on proliferation and apoptosis of gastric cancer SNU-1 cells [J]. Journal of International Oncology, 2023, 50(5): 257-262.
[7]	Zhang Yuxiao, Zhang Liansheng, Li Lijuan. Research status and application prospect of a novel immune checkpoint TIGIT in the immunotherapy of multiple myeloma [J]. Journal of International Oncology, 2023, 50(2): 122-125.
[8]	Zhu Yi, Chen Jian. Mechanism of hydrogen sulfide in tumorigenesis and development and its donor-mediated anti-tumor effects [J]. Journal of International Oncology, 2023, 50(12): 729-733.
[9]	Zhao Jianhao, Duan Yanchao. Research progress in the pathogenesis of extramedullary disease in multiple myeloma [J]. Journal of International Oncology, 2023, 50(1): 55-59.
[10]	Lian Haiwei, Yang Shuorui, Liu Renzhong. Mechanism study on regulation of glioblastoma cell proliferation and apoptosis by sciadopitysin combined with CX-4945 through Notch1 pathway [J]. Journal of International Oncology, 2022, 49(6): 321-326.
[11]	Yang Ya, Ning Xiaofei, Li Bingliang, Yao Hui, Shan Changping, Lyu Min. Study on the mechanism of procyanidin mediated anti gastric cancer SNU-1 cell line by inducing the production of reactive oxygen species [J]. Journal of International Oncology, 2022, 49(5): 257-262.
[12]	Gao Shan, Lu Minqiu, Shi Lei, Chu Bin, Fang Lijuan, Xiang Qiuqing, Wang Yutong, Ding Yuehua, Bao Li. Clinical efficacy and safety of ixazomib-based therapy in the treatment of relapsed or refractory multiple myeloma [J]. Journal of International Oncology, 2022, 49(5): 286-291.
[13]	Jiang Mengting, Wang Jiachun, Zong Jing. Effects of NFAT5 inhibition on proliferation, invasion, migration and apoptosis of lung adenocarcinoma cells [J]. Journal of International Oncology, 2021, 48(6): 321-327.
[14]	Sun Ruijie, Shan Ningning. Immune, targeted therapy and related issues of relapsed/refractory multiple myeloma [J]. Journal of International Oncology, 2021, 48(6): 381-384.
[15]	Wang Xianwei, Shi Meiyan, Wang Fengqin, Qi Fu, Wang Chaozhe, Zhou Fei. Roles of TSA upregulation miR-4298 targeting inhibition of PADI4 expression in inducing U251 cells apoptosis [J]. Journal of International Oncology, 2021, 48(4): 193-199.